N. Nowak

The application of FRAX® to determine intervention thresholds in osteoporosis treatment in Poland.

J. Kanis, H. Johansson, J. Badurski, 2011, Polskie Archiwum Medycyny Wewnetrznej.

The characteristics of osteoporotic fractures in the region of Bialystok (BOS-2). The application of the WHO algorithm, FRAX®BMI and FRAX®BMD assessment tools to determine patients for intervention.

J. Badurski, A. Dobreńko, N. Nowak, 2011, Endokrynologia Polska.

Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial.

J. Lloyd‐Hughes, P. Tak, G. Schett, 2020, The Lancet. Rheumatology.

Thrombopoietin serum levels at the start of mobilization, collection, and transfusion of autologous peripheral blood stem cells

S. Seeber, T. Moritz, M. Flasshove, 1999, Journal of clinical apheresis.